Background and Objective: Acute vasoreactivity testing using inhaled nitric oxide (NO) is performed to determine the treatment strategy in patients with pulmonary hypertension. Operators of the test are exposed to NO and nitrogen dioxide (NO 2 ) to the same extent during the test procedure, but the safety zone for operators in the catheterization laboratory is unclear. This study aimed to clarify the safety zone for operators during the NO inhalation test. Methods: The mask was placed on the examination table in the catheterization laboratory. NO was added using the INOvent ® (INO-Therapeutics, LLC), which was attached to an oxygen line and delivered NO to the mask. During simulated NO inhalation tests (n = 10) in a catheterization laboratory, NO and NO 2 concentrations were measured at nine speci ed locations: at the mask out ow port (E0); 25 cm (E25) and 50 cm (E50) from the mask out ow port; heights of 25 cm (A25) and 50 cm (A50) above E0 and E25; and a height of 25 cm (B25) below E0 and E25. During NO inhalation testing conducted in 5 patients, concentrations of NO and NO 2 were measured at E0 and E25A50. The Steel-Dwass and Student t-tests were used to perform intergroup analyses. Results: NO-E0A25 (0.00 ± 0.00 ppm), NO-E25A25 (0.01 ± 0.10 ppm), NO-E0A50 (0.00 ± 0.00 ppm), and NO-E25A50 (0.00 ± 0.00 ppm) were signicantly lower than NO-E0 (17.01 ± 0.22 ppm), NO-E25 (4.06 ± 0.47 ppm), and NO-E50 (1.90 ± 0.39 ppm) (p < 0.01, all comparisons). NO 2 concentrations were less than 0.1 ppm at all nine locations. NO and NO 2 concentrations were not affected by room temperature (20, 24, or 28 C) or the ow rate of oxygen (15 or 10 L/min). During NO inhalation testing in patients, NO-E25A50 (0.20 ± 0.45 ppm) was signi cantly lower than NO-E0 (7.20 ± 2.39 ppm, p < 0.01); however, no signi cant difference in the NO 2 concentration was seen between NO 2 -E0 (0.220 ± 0.179 ppm) and NO 2 -E25A50 (0.180 ± 0.205 ppm). Conclusions: An operator safety zone in NO vasoreactivity testing is a zone >25 cm in all directions from the mask for NO inhalation. The concentrations of NO and NO 2 to which an operator is exposed in the clinical setting are within the permissible exposure limits de ned by the National Institute for Occupational Safety and Health.
Background
Pulmonary hypertension (PH) is a pathological condition in which the pulmonary artery pressure is persistently increased by various causes, and it is an intractable disease with a poor prognosis that sequentially progresses to right ventricular failure [1, 2] . Although the quality of life and survival rate of patients with PH have improved greatly by the development of PH-speci c treatments, a large number of patients still have a poor outcome. The acute vasoreactivity test with nitric oxide (NO) inhalation is useful for determining the prognosis of patients with pulmonary arterial hypertension [3] [4] [5] [6] [7] and for selecting a therapeutic strategy. However, the NO inhalation test exposes personnel conducting the test to the risk of untoward effects of NO, including headache, dizziness, sore throat, cough, and dyspnea. NO is released into the air from a patient s mask during an NO inhalation test, and it reacts with oxygen, resulting in conversion to a more toxic substance, nitrogen dioxide (NO 2 ), with a half-life in the body of 5 to 10 seconds [8, 9] . The National Institute for Occupational Safety and Health (NIOSH) and other organizations currently recommend that the time-weighted average (TWA) of NO and NO 2 should be 25 ppm or lower and 1.0 ppm or lower, respectively, for persons who work 8 hours per day. To our knowledge [8, 10] , no study has reported changes in NO and NO 2 levels in room air during NO inhalation tests or provided precautions for medical personnel during the test.
Thus, the present study aimed to clarify the safety zone for operators of NO inhalation tests by determining NO and NO 2 levels in different locations during NO inhalation tests in a catheterization laboratory.
Methods
The present study was designed as an environmental survey in a catheterization laboratory, and hence did not require review by the ethics committee of Sapporo Medical University. The present study was conducted in accordance with the World Medical Association Declaration of Helsinki.
To standardize the protocol and to avoid risks to patients, we used a simulated NO inhalation test (a test in a standard clinical setting without a patient) to collect data, and we veri ed the nd-ings from the simulation tests in routine clinical examinations of NO inhalation testing conducted in patients with PH.
Testing room
The experiments were conducted in a catheterization laboratory used for daily clinical practice. The catheterization laboratory had an area of 36 m 2 , and the room air was ventilated 10 times/hour at a rate of 1970 m 3 /hour. The room temperature was set to 24 C, which was the same as that in normal clinical conditions. The room pressure of the catheterization laboratory was maintained at the same level as atmospheric pressure (range 756.6 to 764.3 mmHg). The experiment was performed on an examination table for an angiography test at a height of 90 cm from the oor.
Study materials
The equipment and materials used in the study are shown in Ta [12] .
Experimental methods 2.3.1 Experiment 1-1
The experimental system is shown in Fig. 1 . A reservoir mask was placed on the examination table for NO inhalation testing, and NO gas was added at a concentration of 20 ppm to 100% oxygen and delivered to the mask. Concentrations of NO and NO 2 at the out ow port of the mask (NO-E0 and NO 2 -E0, respectively), at a distance of 25 cm from the mask out ow port (NO-E25 and NO 2 -E25, respectively), and at a distance of 50 cm from the mask out ow port (NO-E50 and NO 2 -E50, respectively) were measured at the level of the examination table 10 minutes after the delivery of NO was started [11] . Additionally, concentrations of NO and NO 2 were measured at 25 cm (A25) and 50 cm (A50) above the examination table at the out ow port of the mask (E0A25 and E0A50, respectively) and at a distance of 25 cm from the mask out ow port (E25A25 and E25A50, respectively). Additionally, at 25 cm below the examination table, concentrations of NO or NO 2 were measured at the out ow port of the mask (E0B25) and at a distance of 25 cm from the mask out ow port (E25B25). Concentrations were measured 10 times at each location in 10 experimental setups to compare mean concentrations of 
Experiment 1-2
Concentrations of NO or NO 2 were measured 10 times at E0, E25, E50, and E25A50 at room temperatures of 20 C (4 C below the routine clinical condition) and 28 C (4 C above the routine clinical condition) to clarify the degree at which diffusion of NO or NO 2 from the out ow port of the mask would be affected by room temperature.
Experiment 1-3
When the ow rate of 100% oxygen, to which NO gas was added at a concentration of 20 ppm, was changed from 15 L/min to 10 L/min, concentrations of NO and NO 2 were measured 10 times at E0, E25, E50, and E25A50.
Experiment 2
During routine clinical examinations of NO inhalation testing in patients with PH, concentrations of NO and NO 2 were measured at E0 and E25. Five patients underwent NO inhalation testing.
Concentrations of NO-E0, NO-E25A50, NO 2 -E0, and NO 2 -E25A50 were measured 10 minutes after the delivery of NO was started.
Statistical analysis
Data are expressed as a mean ± standard deviation. Data were analyzed using the Pharmaco Basic software program (Scientist Press Co., Ltd.). Intergroup comparisons in experiment 1-1 and experiment 1-2 were conducted using the Steel-Dwass test (two-sided), and differences with p < 0.05 were considered significant. Results of experiment 1-3 and experiment 2 were compared using the Student t-test (two-sided), and differences with p < 0.05 were considered signi cant.
Results

Comparisons of NO and NO 2 concentrations
As shown in Fig. 2 , NO-E0 (17.01 ± 0.22 ppm), NO-E25 (4.06 ± 0.47 ppm), and NO-E50 (1.90 ± 0.39 ppm) were signi cantly lower than NO-E0. NO was undetectable at the other sampling points: NO-E0A25, NO-E25A25, NO-E0A50, NO-E25A50, NO-E0B25, and NO-E25B25. There was a signi cant difference between NO-E25 and NO-E50, and NO-E0A25, NO-E25A25, NO-E0A50, NO-E25A50, NO-E0B25 and NO-E25B25 were lower than NO-E50 (p < 0.01). In contrast to the NO concentration, there were no signicant differences in NO 2 concentrations between all sampling points ( Fig. 3) : NO 2 -E0 (0.022 ± 0.063 ppm), NO 2 -E25 (0.008 ± 0.039 ppm), NO 2 -E50 (0.004 ± 0.028 ppm), NO 2 -E0A25 (0.012 ± 0.048 ppm), NO 2 -E25A25 (0.008 ± 0.039 ppm), NO 2 -E0A50 (0.006 ± 0.034 ppm), NO 2 -E25A50 (0.006 ± 0.034 ppm), NO 2 -E0B25 (0.008 ± 0.039 ppm), and NO 2 -E25B25 (0.006 ± 0.034 ppm).
Comparisons of NO and NO 2 concentrations at different room temperatures
In experiment 1-2, the NO concentration at three different room temperatures were compared. There were no signi cant differences in the NO concentration among room temperatures of 20 C, 24 C, and 28 C at all the sampling points: NO-E0 (17.09 ± Fig. 2 Comparisons of nitric oxide (NO) concentrations. NO-E25 and NO-E50 are signi cantly lower than NO-E0. NO-E0A25, NO-E25A25, NO-E0A50, and NO-E25A50 are signi cantly lower than NO-E0, NO-E25, and NO-E50. NO-E0B25 and NO-E25B25 are also signi cantly lower than NO-E0, NO-E25, and NO-E50. E0, mask out ow port; E25, 25 cm from the mask out ow port; E50, 50 cm from the mask outow port; A25, height of 25 cm above the examination 
0.038 ppm, 17.01 ± 0.22 ppm, and 17.11 ± 0.40 ppm); NO-E25 (3.99 ± 0.54 ppm, 4.06 ± 0.47 ppm, and 4.04 ± 0.57 ppm); and NO-E50, (1.78 ± 0.75 ppm, 1.90 ± 0.39 ppm, and 1.74 ± 0.76 ppm). NO was undetectable at E25A50 at any room temperature. Additionally, no signi cant differences in the NO 2 concentration among room temperatures of 20 C, 24 C and 28 C were found at all the sampling points: NO 2 -E0 (0.010 ± 0.044 ppm, 0.022 ± 0.063 ppm, and 0.006 ± 0.034 ppm); NO 2 -E25 (0.002 ± 0.020 ppm, 0.008 ± 0.039 ppm, and 0.004 ± 0.028 ppm); NO 2 -E50 (0.012 ± 0.048 ppm, 0.004 ± 0.028 ppm, and 0.006 ± 0.034 ppm); and NO 2 -E25A50 (0.010 ± 0.044 ppm, 0.006 ± 0.034 ppm, and 0.008 ± 0.039 ppm).
Comparisons of NO and NO 2 concentrations between different ow rates of oxygen gas
In experiment 1-3, the NO concentration was compared between two ow rates of 100% oxygen. No signi cant differences in the NO concentration between ow rates of 15 and 10 L/min of 100% oxygen were found at all the sampling points: NO-E0 (17.01 ± 0.22 ppm and 17.07 ± 0.29 ppm); NO-E25 (4.06 ± 0.47 ppm and 4.18 ± 0.44 ppm; and NO-E50 (1.90 ± 0.39 ppm and 2.02 ± 0.51 ppm). NO was undetectable at E25A50 at both ow rates of 100% oxygen. There were no signi cant differences in NO 2 concentrations between ow rates of 15 and 10 L/min of 100% oxygen at all the sampling points: NO 2 -E0 (0.022 ± 0.063 ppm and 0.016 ± 0.055 ppm); NO 2 -E25 (0.008 ± 0.039 ppm and 0.010 ± 0.044 ppm); NO 2 -E50 (0.004 ± 0.028 ppm and 0.016 ± 0.055 ppm); and NO 2 -E25A50 (0.006 ± 0.034 ppm and 0.008 ± 0.039 ppm). Table 2 shows the NO and NO 2 concentrations in clinical examinations of NO inhalation testing in ve patients suspected to have PH, and Fig. 4 shows comparisons of these concentrations. NO-E25A50 (0.20 ± 0.45 ppm, p < 0.01) was signi cantly lower than NO-E0 (7.20 ± 2.39 ppm). However, there was no signi cant difference in the NO 2 concentration between NO 2 -E0 (0.220 ± 0.179 ppm) and NO 2 -E25A50 (0.180 ± 0.205 ppm).
Comparisons of NO and NO 2 concentrations in NO inhalation testing in patients with PH
Discussion
In the present study, the NO 2 concentration was markedly lower than the expected value. NO reacts with oxygen in the atmosphere and is oxidized to NO 2 , but its oxidation rate depends on the ambient temperature, as well as oxygen and NO concentrations. At room temperature and atmospheric pressure, NO and NO 2 exist in an equilibrium mixture, with the percentage of NO 2 being about 5% [13] . However, as shown in Fig. 2 and 3 , the concentration of NO at the measurement point E0 was approximately 900 times higher than that of NO 2 . Standard deviations for the NO concentration were smaller compared to those for NO 2 , which were considerably larger. There are a few possible explanations for these results. First, NO 2 could have settled around the lower part of the mask because of its higher speci c gravity (1.58) than NO (1.06), and this would account for the relatively low concentration measured in the upper part of the mask.
Underestimation of the NO 2 concentration and measurement NO-E25A50 is signi cantly lower than NO-E0. However, no signi cant difference in NO 2 concentration is found between NO 2 -E0 and NO 2 -E25A50. NS, not signi cant; E0, mask out ow port; E25, 25 cm from the mask out ow port; A50, 50 cm above the examination 
variability may have occurred because the measurement point E0 was positioned near the aperture of the out ow port located in the upper part of the mask. Second, the same system was used to measure NO and NO 2 concentrations in the present study. Although data variation in measurements by the Testo 350 XL used in this study is reported to be ±5% or less for both NO and NO 2 , the data for variations were based on measurements of a comparatively high concentration of the gases (500 ppm). It is possible that data reproducibility with the Testo 350 XL depends on the concentration of NO 2 and is lower for low levels of NO 2 . Third, measurements may have become more vulnerable to technical error when sampling was performed under random air ow around the measurement system. NO 2 is more toxic than NO [14] . Known acute symptoms induced by NO 2 include sore throat, cough, dizziness, headache, nausea, and chest pain [14] . The American Conference of Governmental Industrial Hygienists and Japan Society for Occupational Health set the TWA value of 3 ppm as the permissible exposure limit for workers working for 8 hours per day and 40 hours per week on average, and set the short-term exposure limit to 5 ppm for workers working for short periods intermittently (e.g., 15 minutes × 4 times) [8, 10] . Few reports have measured NO 2 concentrations during NO inhalation testing in an examination room, and the status of NO 2 exposure for operators is currently unknown. The present study demonstrated that the concentration of NO 2 to which operators are exposed does not reach a hazardous concentration, unless the test is performed under special conditions. However, one study has shown the development of asymptomatic pulmonary dysfunction with the inhalation of NO 2 at 0.3-0.5 ppm, which is lower than the aforementioned limits, and induction of asthmatic attacks in asthmatic patients [14] . We detected NO 2 at a distance of 50 cm from a reservoir mask at a concentration similar to that inside the reservoir mask, although the concentration did not exceed the TWA permissible exposure limit. The results indicate that an operator can be exposed to NO 2 , and adverse events may occur due to NO 2 exposure even at a sufcient distance from the patient subjected to an NO inhalation test. The results also suggest that the risk of adverse events increases if an operator has allergic diseases or if the time of examination is prolonged under speci c conditions. Since operators are exposed to NO 2 during NO inhalation testing, despite the concentration being within the allowance range, it is necessary to be aware of the potential risk of adverse events and the countermeasures.
The present ndings showed the distance from a reservoir mask at which the operator s NO exposure level decreased signicantly. The NO concentration was signi cantly decreased at a height of 25 cm above the mask compared to that at the surface of the examination table. Our results are explained by the fact that NO is slightly heavier than air. Additionally, our results con rmed that the concentration of NO or NO 2 to which an operator is exposed in the clinical setting is within the permissible limit during NO inhalation testing, because the mouth and nose of an operator or operating room worker is at a height of more than 25 cm, which is usually more than 50 cm above the level of a reservoir mask. Verifying changes in NO and NO 2 levels in room air during NO inhalation can provide important information for establishing a standardized protocol to ensure operators safety during acute vasoreactivity tests in the future.
The present study has several limitations. First, the study protocol did not consider concentrations of NO and NO 2 contained in expired air from operators or operating room nurses. The amount of NO 2 may be affected by expired air from operating room workers when it is higher than usual. Second, the disturbance of air ow by the movement of operators and the arrangement of large equipment in an examination room cannot be neglected in the clinical setting. Further studies performed under various conditions are needed to af rm the operator safety zone in the clinical setting.
Conclusions
We measured concentrations of NO and NO 2 in a catheterization laboratory during NO inhalation testing and showed that an operator safety zone in NO vasoreactivity testing is a zone more than 25 cm in all directions from the mask for NO inhalation. The concentrations of NO and NO 2 to which an operator is exposed in the clinical setting are within the permissible exposure limits de ned by NIOSH.
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